APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Smoking Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-Smoking Products Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchAnti-Smoking Products Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Smoking Products Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Anti-Smoking Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Smoking Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Smoking Products Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-Smoking Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Anti-Smoking Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-Smoking Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-Smoking Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-Smoking Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Anti-Smoking Products include Takeda pharmaceutical, Novartis International, Pfizer, GSK, VMR products, VaporCorp, Revolymer plc, NJOY and McNeil AB, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Anti-Smoking Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-Smoking Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-Smoking Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Smoking Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Smoking Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anti-Smoking Products revenue, projected growth trends, production technology, application and end-user industry.

Anti-Smoking Products Segment by Company

Takeda pharmaceutical

Novartis International

Pfizer

GSK

VMR products

VaporCorp

Revolymer plc

NJOY

McNeil AB

Lorillard

Imperial Tobacco

Elder Pharma

Cipla

Anti-Smoking Products Segment by Type

Drug therapy

Nicotine Replacement Therapy

E-cigarettes

Anti-Smoking Products Segment by Application

Smokers aged 65 years or older

Smokers aged 45–64

Smokers aged 25–44

Smokers aged 18–24

Anti-Smoking Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Smoking Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Smoking Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Smoking Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anti-Smoking Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anti-Smoking Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Smoking Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Smoking Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug therapy Major Player Table 3. Nicotine Replacement Therapy Major Player Table 4. E-cigarettes Major Player Table 5. Global Anti-Smoking Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Smokers aged 65 years or older Major Player Table 7. Smokers aged 45–64 Major Player Table 8. Smokers aged 25–44 Major Player Table 9. Smokers aged 18–24 Major Player Table 10. Anti-Smoking Products Industry Trends Table 11. Anti-Smoking Products Industry Drivers Table 12. Anti-Smoking Products Industry Opportunities and Challenges Table 13. Anti-Smoking Products Industry Restraints Table 14. Global Anti-Smoking Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Anti-Smoking Products Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Anti-Smoking Products Market Share by Region (2021-2026) Table 17. Global Anti-Smoking Products Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Anti-Smoking Products Market Share by Region (2027-2032) Table 19. Global Anti-Smoking Products Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Anti-Smoking Products Revenue Market Share by Players (2021-2026) Table 21. Global Anti-Smoking Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Anti-Smoking Products Key Players Headquarters & Area Served Table 23. Global Anti-Smoking Products Players, Product Type & Application Table 24. Global Anti-Smoking Products Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Anti-Smoking Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Anti-Smoking Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Anti-Smoking Products Revenue Market Share by Type (2021-2026) Table 31. Global Anti-Smoking Products Revenue Market Share by Type (2027-2032) Table 32. Global Anti-Smoking Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Anti-Smoking Products Revenue Market Share by Application (2021-2026) Table 36. Global Anti-Smoking Products Revenue Market Share by Application (2027-2032) Table 37. Takeda pharmaceutical Company Information Table 38. Takeda pharmaceutical Business Overview Table 39. Takeda pharmaceutical Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Takeda pharmaceutical Anti-Smoking Products Product Portfolio Table 41. Takeda pharmaceutical Recent Development Table 42. Novartis International Company Information Table 43. Novartis International Business Overview Table 44. Novartis International Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Novartis International Anti-Smoking Products Product Portfolio Table 46. Novartis International Recent Development Table 47. Pfizer Company Information Table 48. Pfizer Business Overview Table 49. Pfizer Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Pfizer Anti-Smoking Products Product Portfolio Table 51. Pfizer Recent Development Table 52. GSK Company Information Table 53. GSK Business Overview Table 54. GSK Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. GSK Anti-Smoking Products Product Portfolio Table 56. GSK Recent Development Table 57. VMR products Company Information Table 58. VMR products Business Overview Table 59. VMR products Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. VMR products Anti-Smoking Products Product Portfolio Table 61. VMR products Recent Development Table 62. VaporCorp Company Information Table 63. VaporCorp Business Overview Table 64. VaporCorp Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. VaporCorp Anti-Smoking Products Product Portfolio Table 66. VaporCorp Recent Development Table 67. Revolymer plc Company Information Table 68. Revolymer plc Business Overview Table 69. Revolymer plc Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Revolymer plc Anti-Smoking Products Product Portfolio Table 71. Revolymer plc Recent Development Table 72. NJOY Company Information Table 73. NJOY Business Overview Table 74. NJOY Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. NJOY Anti-Smoking Products Product Portfolio Table 76. NJOY Recent Development Table 77. McNeil AB Company Information Table 78. McNeil AB Business Overview Table 79. McNeil AB Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. McNeil AB Anti-Smoking Products Product Portfolio Table 81. McNeil AB Recent Development Table 82. Lorillard Company Information Table 83. Lorillard Business Overview Table 84. Lorillard Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Lorillard Anti-Smoking Products Product Portfolio Table 86. Lorillard Recent Development Table 87. Imperial Tobacco Company Information Table 88. Imperial Tobacco Business Overview Table 89. Imperial Tobacco Anti-Smoking Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Imperial Tobacco Anti-Smoking Products Product Portfolio Table 91. Imperial Tobacco Recent Development Table 92. Elder Pharma Company Information Table 93. Elder Pharma Business Overview Table 94. Elder Pharma Anti-Smoking Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Elder Pharma Anti-Smoking Products Product Portfolio Table 96. Elder Pharma Recent Development Table 97. Cipla Company Information Table 98. Cipla Business Overview Table 99. Cipla Anti-Smoking Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Cipla Anti-Smoking Products Product Portfolio Table 101. Cipla Recent Development Table 102. North America Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Anti-Smoking Products Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Anti-Smoking Products Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Anti-Smoking Products Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Anti-Smoking Products Revenue by Country (US$ Million) & (2027-2032) Table 116. China Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 117. China Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 118. China Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 119. China Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Anti-Smoking Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Anti-Smoking Products Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Anti-Smoking Products Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Anti-Smoking Products Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Anti-Smoking Products Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Anti-Smoking Products Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Anti-Smoking Products Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Anti-Smoking Products Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Anti-Smoking Products Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Anti-Smoking Products Image Figure 2. Global Anti-Smoking Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Smoking Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug therapy Image Figure 5. Nicotine Replacement Therapy Image Figure 6. E-cigarettes Image Figure 7. Global Anti-Smoking Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Anti-Smoking Products Market Size Share 2021 VS 2025 VS 2032 Figure 9. Smokers aged 65 years or older Image Figure 10. Smokers aged 45–64 Image Figure 11. Smokers aged 25–44 Image Figure 12. Smokers aged 18–24 Image Figure 13. Global Anti-Smoking Products Market Size (US$ Million) & (2021-2032) Figure 14. Global Anti-Smoking Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Anti-Smoking Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Anti-Smoking Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Anti-Smoking Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Anti-Smoking Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Anti-Smoking Products Revenue Market Share by Type (2021-2032) Figure 21. Global Anti-Smoking Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Anti-Smoking Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Anti-Smoking Products Revenue Market Share by Application (2021-2032) Figure 24. North America Anti-Smoking Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Anti-Smoking Products Revenue Share by Type (2021-2032) Figure 26. North America Anti-Smoking Products Revenue Share by Application (2021-2032) Figure 27. North America Anti-Smoking Products Revenue Share by Country (2021-2032) Figure 28. United States Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Anti-Smoking Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Anti-Smoking Products Revenue Share by Type (2021-2032) Figure 33. Europe Anti-Smoking Products Revenue Share by Application (2021-2032) Figure 34. Europe Anti-Smoking Products Revenue Share by Country (2021-2032) Figure 35. Germany Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Anti-Smoking Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Anti-Smoking Products Revenue Share by Type (2021-2032) Figure 45. China Anti-Smoking Products Revenue Share by Application (2021-2032) Figure 46. Asia Anti-Smoking Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Anti-Smoking Products Revenue Share by Type (2021-2032) Figure 48. Asia Anti-Smoking Products Revenue Share by Application (2021-2032) Figure 49. Asia Anti-Smoking Products Revenue Share by Region (2021-2032) Figure 50. Japan Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Anti-Smoking Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Anti-Smoking Products Revenue Share by Type (2021-2032) Figure 58. SAMEA Anti-Smoking Products Revenue Share by Application (2021-2032) Figure 59. SAMEA Anti-Smoking Products Revenue Share by Country (2021-2032) Figure 60. Brazil Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Anti-Smoking Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Drug therapy
  • Nicotine Replacement Therapy
  • E-cigarettes
Applications
  • Smokers aged 65 years or older
  • Smokers aged 45–64
  • Smokers aged 25–44
  • Smokers aged 18–24
Companies covered
  • Takeda pharmaceutical
  • Novartis International
  • Pfizer
  • GSK
  • VMR products
  • VaporCorp
  • Revolymer plc
  • NJOY
  • McNeil AB
  • Lorillard
  • Imperial Tobacco
  • Elder Pharma
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-Smoking Products Market by Type
  3. 1.2.1 Global Anti-Smoking Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug therapy
  5. 1.2.3 Nicotine Replacement Therapy
  6. 1.2.4 E-cigarettes
  7. 1.3 Anti-Smoking Products Market by Application
  8. 1.3.1 Global Anti-Smoking Products Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Smokers aged 65 years or older
  10. 1.3.3 Smokers aged 45–64
  11. 1.3.4 Smokers aged 25–44
  12. 1.3.5 Smokers aged 18–24
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Anti-Smoking Products Market Dynamics
  1. 2.1 Anti-Smoking Products Industry Trends
  2. 2.2 Anti-Smoking Products Industry Drivers
  3. 2.3 Anti-Smoking Products Industry Opportunities and Challenges
  4. 2.4 Anti-Smoking Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anti-Smoking Products Market Perspective (2021-2032)
  2. 3.2 Global Anti-Smoking Products Growth Trends by Region
  3. 3.2.1 Global Anti-Smoking Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-Smoking Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Anti-Smoking Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anti-Smoking Products Revenue by Players
  2. 4.1.1 Global Anti-Smoking Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Anti-Smoking Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anti-Smoking Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-Smoking Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anti-Smoking Products Key Players Headquarters & Area Served
  7. 4.4 Global Anti-Smoking Products Players, Product Type & Application
  8. 4.5 Global Anti-Smoking Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anti-Smoking Products Market CR5 and HHI
  11. 4.6.3 2025 Anti-Smoking Products Tier 1, Tier 2, and Tier 3
5 Anti-Smoking Products Market Size by Type
  1. 5.1 Global Anti-Smoking Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-Smoking Products Revenue by Type (2021-2032)
  3. 5.3 Global Anti-Smoking Products Revenue Market Share by Type (2021-2032)
6 Anti-Smoking Products Market Size by Application
  1. 6.1 Global Anti-Smoking Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anti-Smoking Products Revenue by Application (2021-2032)
  3. 6.3 Global Anti-Smoking Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda pharmaceutical
  2. 7.1.1 Takeda pharmaceutical Company Information
  3. 7.1.2 Takeda pharmaceutical Business Overview
  4. 7.1.3 Takeda pharmaceutical Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda pharmaceutical Anti-Smoking Products Product Portfolio
  6. 7.1.5 Takeda pharmaceutical Recent Developments
  7. 7.2 Novartis International
  8. 7.2.1 Novartis International Company Information
  9. 7.2.2 Novartis International Business Overview
  10. 7.2.3 Novartis International Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novartis International Anti-Smoking Products Product Portfolio
  12. 7.2.5 Novartis International Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Anti-Smoking Products Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GSK Anti-Smoking Products Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 VMR products
  26. 7.5.1 VMR products Company Information
  27. 7.5.2 VMR products Business Overview
  28. 7.5.3 VMR products Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 VMR products Anti-Smoking Products Product Portfolio
  30. 7.5.5 VMR products Recent Developments
  31. 7.6 VaporCorp
  32. 7.6.1 VaporCorp Company Information
  33. 7.6.2 VaporCorp Business Overview
  34. 7.6.3 VaporCorp Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  35. 7.6.4 VaporCorp Anti-Smoking Products Product Portfolio
  36. 7.6.5 VaporCorp Recent Developments
  37. 7.7 Revolymer plc
  38. 7.7.1 Revolymer plc Company Information
  39. 7.7.2 Revolymer plc Business Overview
  40. 7.7.3 Revolymer plc Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Revolymer plc Anti-Smoking Products Product Portfolio
  42. 7.7.5 Revolymer plc Recent Developments
  43. 7.8 NJOY
  44. 7.8.1 NJOY Company Information
  45. 7.8.2 NJOY Business Overview
  46. 7.8.3 NJOY Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NJOY Anti-Smoking Products Product Portfolio
  48. 7.8.5 NJOY Recent Developments
  49. 7.9 McNeil AB
  50. 7.9.1 McNeil AB Company Information
  51. 7.9.2 McNeil AB Business Overview
  52. 7.9.3 McNeil AB Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  53. 7.9.4 McNeil AB Anti-Smoking Products Product Portfolio
  54. 7.9.5 McNeil AB Recent Developments
  55. 7.10 Lorillard
  56. 7.10.1 Lorillard Company Information
  57. 7.10.2 Lorillard Business Overview
  58. 7.10.3 Lorillard Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lorillard Anti-Smoking Products Product Portfolio
  60. 7.10.5 Lorillard Recent Developments
  61. 7.11 Imperial Tobacco
  62. 7.11.1 Imperial Tobacco Company Information
  63. 7.11.2 Imperial Tobacco Business Overview
  64. 7.11.3 Imperial Tobacco Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Imperial Tobacco Anti-Smoking Products Product Portfolio
  66. 7.11.5 Imperial Tobacco Recent Developments
  67. 7.12 Elder Pharma
  68. 7.12.1 Elder Pharma Company Information
  69. 7.12.2 Elder Pharma Business Overview
  70. 7.12.3 Elder Pharma Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Elder Pharma Anti-Smoking Products Product Portfolio
  72. 7.12.5 Elder Pharma Recent Developments
  73. 7.13 Cipla
  74. 7.13.1 Cipla Company Information
  75. 7.13.2 Cipla Business Overview
  76. 7.13.3 Cipla Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cipla Anti-Smoking Products Product Portfolio
  78. 7.13.5 Cipla Recent Developments
8 North America
  1. 8.1 North America Anti-Smoking Products Revenue (2021-2032)
  2. 8.2 North America Anti-Smoking Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Anti-Smoking Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Anti-Smoking Products Revenue by Type (2027-2032)
  5. 8.3 North America Anti-Smoking Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Anti-Smoking Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Anti-Smoking Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Anti-Smoking Products Revenue by Application (2027-2032)
  9. 8.5 North America Anti-Smoking Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Anti-Smoking Products Revenue by Country
  11. 8.6.1 North America Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anti-Smoking Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Anti-Smoking Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Anti-Smoking Products Revenue (2021-2032)
  2. 9.2 Europe Anti-Smoking Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anti-Smoking Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anti-Smoking Products Revenue by Type (2027-2032)
  5. 9.3 Europe Anti-Smoking Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anti-Smoking Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anti-Smoking Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anti-Smoking Products Revenue by Application (2027-2032)
  9. 9.5 Europe Anti-Smoking Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anti-Smoking Products Revenue by Country
  11. 9.6.1 Europe Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anti-Smoking Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anti-Smoking Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Anti-Smoking Products Revenue (2021-2032)
  2. 10.2 China Anti-Smoking Products Revenue by Type (2021-2032)
  3. 10.2.1 China Anti-Smoking Products Revenue by Type (2021-2026)
  4. 10.2.2 China Anti-Smoking Products Revenue by Type (2027-2032)
  5. 10.3 China Anti-Smoking Products Revenue Share by Type (2021-2032)
  6. 10.4 China Anti-Smoking Products Revenue by Application (2021-2032)
  7. 10.4.1 China Anti-Smoking Products Revenue by Application (2021-2026)
  8. 10.4.2 China Anti-Smoking Products Revenue by Application (2027-2032)
  9. 10.5 China Anti-Smoking Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-Smoking Products Revenue (2021-2032)
  2. 11.2 Asia Anti-Smoking Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anti-Smoking Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anti-Smoking Products Revenue by Type (2027-2032)
  5. 11.3 Asia Anti-Smoking Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anti-Smoking Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anti-Smoking Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anti-Smoking Products Revenue by Application (2027-2032)
  9. 11.5 Asia Anti-Smoking Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anti-Smoking Products Revenue by Country
  11. 11.6.1 Asia Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anti-Smoking Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anti-Smoking Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-Smoking Products Revenue (2021-2032)
  2. 12.2 SAMEA Anti-Smoking Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anti-Smoking Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anti-Smoking Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anti-Smoking Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anti-Smoking Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anti-Smoking Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anti-Smoking Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anti-Smoking Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anti-Smoking Products Revenue by Country
  11. 12.6.1 SAMEA Anti-Smoking Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anti-Smoking Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anti-Smoking Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst